Biogen Says Investors Can't Expand Alzheimer's Drug Suit
By Sydney Price · October 7, 2025, 8:54 PM EDT
Biogen Inc. said a class of investors suing over alleged misleading statements in connection with the rollout of the company's Alzheimer's drug should not be allowed to needlessly delay resolution by...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login